Laminar distribution of cholinergic- and serotonergic-dependent plasticity within kitten visual cortex.
Both cholinergic and serotonergic modulatory projections to mammalian striate cortex have been demonstrated to be involved in the regulation of postnatal plasticity, and a striking alteration in the number and intracortical distribution of cholinergic and serotonergic receptors takes place during the critical period for cortical plasticity. As well, agonists of cholinergic and serotonergic receptors have been demonstrated to facilitate induction of long-term synaptic plasticity in visual cortical slices supporting their involvement in the control of activity-dependent plasticity. We recorded field potentials from layers 4 and 2/3 in visual cortex slices of 60--80 day old kittens after white matter stimulation, before and after a period of high frequency stimulation (HFS), in the absence or presence of either cholinergic or serotonergic agonists. At these ages, the HFS protocol alone almost never induced long-term changes of synaptic plasticity in either layers 2/3 or 4. In layer 2/3, agonist stimulation of m1 receptors facilitated induction of long-term potentiation (LTP) with HFS stimulation, while the activation of serotonergic receptors had only a modest effect. By contrast, a strong serotonin-dependent LTP facilitation and insignificant muscarinic effects were observed after HFS within layer 4. The results show that receptor-dependent laminar stratification of synaptic modifiability occurs in the cortex at these ages. This plasticity may underly a control system gating the experience-dependent changes of synaptic organization within developing visual cortex.
Brain Research Centre, University of British Columbia and Vancouver Hospital and Health Sciences Centre, 2550 Willow Street, Vancouver, British Columbia, Canada V5Z 3N9. kojic@ecc.ubc.ca
L
L
Kojic
Q
Q
Gu
R M
RM
Douglas
M S
MS
Cynader
D000818:Animals; D002415:Cats; D018679:Cholinergic Agonists / Q000494:pharmacology*; D004558:Electric Stimulation / Q000379:methods; D066298:In Vitro Techniques; D017774:Long-Term Potentiation / Q000187:drug effects; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D009473:Neuronal Plasticity / Q000187:drug effects*; D043643:Receptor, Muscarinic M1; D043585:Receptor, Muscarinic M2; D044405:Receptor, Serotonin, 5-HT2C; D011976:Receptors, Muscarinic / Q000378:metabolism; D011985:Receptors, Serotonin / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology; D017366:Serotonin Receptor Agonists / Q000494:pharmacology*; D009435:Synaptic Transmission / Q000187:drug effects; D014793:Visual Cortex / Q000187:drug effects* / Q000378:metabolism*
D018679:Cholinergic Agonists; D043643:Receptor, Muscarinic M1; D043585:Receptor, Muscarinic M2; D044405:Receptor, Serotonin, 5-HT2C; D011976:Receptors, Muscarinic; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists; D012701:Serotonin